サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571672

気管支生検デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年

Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
気管支生検デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年
出版日: 2024年09月18日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

気管支生検デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、気管支生検デバイスの世界市場規模は、2024年から2030年にかけてCAGR 7.39%で成長し、2030年には10億2,000万米ドルに達する見込みです。

市場成長の主な要因の1つは、呼吸器疾患の診断に気管支生検デバイスの利用が増加していることと、使い捨て装置の採用が増加していることです。さらに、急速な技術進歩や呼吸器疾患に関する意識向上や検診の増加も市場拡大に寄与しています。

医療技術の進歩は、診断手技の精度、安全性、有効性を向上させることで市場の成長を大きく後押ししています。EBUS-TBNAなどの技術革新は、特に到達困難な領域において、より正確な肺組織のサンプリングを可能にします。このような低侵襲的手技は、患者の不快感を最小限に抑え、合併症のリスクを低減し、従来の手術法に比べて回復時間を短縮します。さらに、各社は確固たるプレゼンスを確立するため、技術的に先進的な製品を携えて市場に参入しています。例えば、オリンパスは2021年5月に肺がんの診断と病期分類のための気管支内超音波（EBUS）気管支鏡BF-UC190Fを発売し、製品ポートフォリオを拡大しました。

さらに、様々な機関が主導する意識向上とスクリーニングの取り組みが、気管支生検デバイスの需要を大きく牽引しています。肺がんは世界的に最も罹患率が高く、死亡率の高いがんのひとつであることから、米国肺協会やWHOなどの団体は早期発見・早期診断を推進する取り組みを強化しています。2024年8月、世界肺がんデーを記念して、国際呼吸器学会フォーラムは、喘息のための世界・イニシアティブを設立メンバーとして、肺がんに対する認識を高め、早期スクリーニングを行い、肺がん診断と治療へのアクセスを改善することの重要な必要性を強調しました。

さらに、COVID-19パンデミックは、パンデミックの初期に観察された肺がんの診断と治療の混乱によって証明されるように、気管支生検デバイス市場に中程度のマイナスの影響を与えました。Elsevier Espana SLUが実施した調査によると、2021年7月、スペインのある大学病院では、2020年3月23日から6月21日までの強制隔離により、肺がんの診断件数が大幅に減少しました。この減少は、診察、診断検査、必要でない処置のキャンセルや遅延によるもので、その結果、肺生検＆検診の受診数が減少しました。

気管支生検デバイス市場レポートハイライト：

  • 製品別では、経気管支針吸引（TBNA）針セグメントが2023年に62.18%の最大収益シェアを占め、予測期間中に最も高いCAGRでの成長が見込まれます。さらに、凍結生検装置（クライオプローブ）セグメントは予測期間中に大きく成長すると予測されています。
  • EBUS-TBNAセグメントは2023年に最大の市場シェアを占めました。EBUS-TBNAは低侵襲技術であり、大手術を必要とせずに肺とその周囲のリンパ節から組織サンプルを採取できるためです。
  • 2023年には、北米が40％以上のシェアを占め、市場を独占しました。これは、強固なヘルスケアインフラと革新的な診断ツールの採用が増加しているためです。
  • 同市場の主要企業は、提携、協業、製品発売など、いくつかの戦略を採用し、製品提供の拡大と市場シェアの拡大を図っています。例えば、2024年5月、Cook Medical社は、次世代EchoTip AcuCore内視鏡超音波（EUS）生検針を米国で発表しました。これは、消化管内の硬膜外および粘膜下病変リンパ節、縦隔腫瘤、腹腔内腫瘤のFNBに超音波内視鏡とともに使用されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場脅威分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
    • COVID-19の影響分析

第4章 製品のビジネス分析

  • 製品市場シェア、2023年および2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測および動向分析、製品別、2018～2030年
  • 生検鉗子
    • 気管支生検鉗子市場、耐久性別、2018年-2030年
    • 使い捨て
    • 再利用可能
  • 経気管支穿刺吸引（TBNA）針
    • 経気管支針吸引（TBNA）針市場、2018年-2030年
    • 従来型
    • EBUS-TBNA
  • 細胞診用ブラシ
    • 細胞診用ブラシ市場、2018年-2030年
  • クライオバイオプシー装置
    • クライオバイオプシー装置市場、耐久性別、2018年-2030年
    • 使い捨て
    • 再利用可能

第5章 地域の推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 北米の気管支生検デバイス市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の気管支生検デバイス市場推計・予測、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • アジア太平洋地域の気管支生検デバイス市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの気管支生検デバイス市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ気管支生検デバイス市場推計・予測、2018-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Medtronic
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Telemed Systems, Inc.
    • HOBBS MEDICAL INC
    • Becton, Dickinson and Company（BD）
    • Olympus Corporation
    • Horizons International Corp.
    • Argon Medical Devices
    • Erbe Elektromedizin GmbH
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 4. North America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 5. North America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 6. U.S. bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7. Canada bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. Mexico bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9. Europe bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. UK bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11. Germany bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. France bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 13. Italy bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14. Spain bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Norway bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16. Denmark bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. Sweden bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18. Asia Pacific bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 19. Asia Pacific bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20. Japan bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. China bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22. India bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Australia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24. South Korea bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Thailand bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26. Latin America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 27. Latin America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28. Brazil bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Argentina bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30. Middle East & Africa bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 31. Middle East & Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 32. South Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33. Saudi Arabia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. UAE bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35. Kuwait bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Information procurement
  • Fig. 3. Primary research pattern
  • Fig. 4. Market research approaches
  • Fig. 5. Value chain-based sizing & forecasting
  • Fig. 6. Market formulation & validation
  • Fig. 7. Market segmentation
  • Fig. 8. Market snapshot
  • Fig. 9. Segment snapshot
  • Fig. 10. Competitive landscape snapshot
  • Fig. 11. Market trends & outlook
  • Fig. 12. PESTLE analysis
  • Fig. 13. Porter's five forces analysis
  • Fig. 14. Bronchial biopsy devices market: Product outlook and key takeaways
  • Fig. 15. Bronchial biopsy devices market: Product movement analysis
  • Fig. 16. Biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 17. Disposable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 18. Reusable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 19. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
  • Fig. 20. Conventional market, 2018 - 2030 (USD Million)
  • Fig. 21. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • Fig. 22. Cytology brushes market, 2018 - 2030 (USD Million)
  • Fig. 23. Cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 24. Disposable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 25. Reusable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 26. Regional marketplace: Key takeaways
  • Fig. 27. Regional outlook, 2023 & 2030
  • Fig. 28. Bronchial biopsy devices market : Region movement analysis
  • Fig. 29. North America bronchial biopsy devices market , 2018 - 2030 (USD Million)
  • Fig. 30. U.S. bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 31. Key country dynamics
  • Fig. 32. Canada bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 33. Key country dynamics
  • Fig. 34. Mexico bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 35. Key country dynamics
  • Fig. 36. Europe bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 37. UK bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 38. Key country dynamics
  • Fig. 39. Germany bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 40. Key country dynamics
  • Fig. 41. France bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 42. Key country dynamics
  • Fig. 43. Italy bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 44. Key country dynamics
  • Fig. 45. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 46. Key country dynamics
  • Fig. 47. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 48. Key country dynamics
  • Fig. 49. Norway bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 50. Key country dynamics
  • Fig. 51. Denmark bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 52. Key country dynamics
  • Fig. 53. Sweden bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 54. Key country dynamics
  • Fig. 55. Asia Pacific bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 56. Japan bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 57. Key country dynamics
  • Fig. 58. China bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 59. Key country dynamics
  • Fig. 60. India bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 61. Key country dynamics
  • Fig. 62. Australia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 63. Key country dynamics
  • Fig. 64. South Korea bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 65. Key country dynamics
  • Fig. 66. Thailand bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 67. Key country dynamics
  • Fig. 68. Latin America bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 69. Brazil bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 70. Key country dynamics
  • Fig. 71. Argentina bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 72. Key country dynamics
  • Fig. 73. Middle East and Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 74. South Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 75. Key country dynamics
  • Fig. 76. Saudi Arabia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 77. Key country dynamics
  • Fig. 78. UAE bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 79. Key country dynamics
  • Fig. 80. Kuwait bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 81. Key country dynamics
  • Fig. 82. Company categorization
  • Fig. 83. Strategy mapping
  • Fig. 84. Company market position analysis
目次
Product Code: GVR-4-68040-126-7

Bronchial Biopsy Devices Market Growth & Trends:

The global bronchial biopsy devices market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier Espana SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

Bronchial Biopsy Devices Market Report Highlights:

  • Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
  • The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
  • In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
  • Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
      • 3.2.1.2. Rising adoption of disposable devices
      • 3.2.1.3. Rapid technological advancements
      • 3.2.1.4. Increasing awareness and screening initiatives by organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of alternative solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Threat Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Biopsy Forceps
    • 4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
    • 4.4.2. Disposable
      • 4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.4.3. Reusable
      • 4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
  • 4.5. Transbronchial needle aspiration (TBNA) needles
    • 4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
    • 4.5.2. Conventional
      • 4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
    • 4.5.3. EBUS-TBNA
      • 4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • 4.6. Cytology Brushes
    • 4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
  • 4.7. Cryobiopsy Devices
    • 4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Disposable market, 2018 - 2030 (USD Million)

Chapter 5. Regional Estimates & Trend Analysis by Component

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key country dynamic
      • 5.4.2.2. Regulatory framework/reimbursement scenario
      • 5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key country dynamic
      • 5.4.3.2. Regulatory framework/reimbursement scenario
      • 5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key country dynamic
      • 5.4.4.2. Regulatory framework/reimbursement scenario
      • 5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key country dynamic
      • 5.5.2.2. Regulatory framework/reimbursement scenario
      • 5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key country dynamic
      • 5.5.3.2. Regulatory framework/reimbursement scenario
      • 5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key country dynamic
      • 5.5.4.2. Regulatory framework/reimbursement scenario
      • 5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key country dynamic
      • 5.5.5.2. Regulatory framework/reimbursement scenario
      • 5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key country dynamic
      • 5.5.6.2. Regulatory framework/reimbursement scenario
      • 5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key country dynamic
      • 5.5.7.2. Regulatory framework/reimbursement scenario
      • 5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamic
      • 5.5.8.2. Regulatory framework/reimbursement scenario
      • 5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key country dynamic
      • 5.5.9.2. Regulatory framework/reimbursement scenario
      • 5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key country dynamic
      • 5.6.2.2. Regulatory framework/reimbursement scenario
      • 5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key country dynamic
      • 5.6.3.2. Regulatory framework/reimbursement scenario
      • 5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key country dynamic
      • 5.6.4.2. Regulatory framework/reimbursement scenario
      • 5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamic
      • 5.6.5.2. Regulatory framework/reimbursement scenario
      • 5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key country dynamic
      • 5.6.6.2. Regulatory framework/reimbursement scenario
      • 5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key country dynamic
      • 5.6.7.2. Regulatory framework/reimbursement scenario
      • 5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key country dynamic
      • 5.7.2.2. Regulatory framework/reimbursement scenario
      • 5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key country dynamic
      • 5.7.3.2. Regulatory framework/reimbursement scenario
      • 5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key country dynamic
      • 5.8.2.2. Regulatory framework/reimbursement scenario
      • 5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key country dynamic
      • 5.8.3.2. Regulatory framework/reimbursement scenario
      • 5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key country dynamic
      • 5.8.4.2. Regulatory framework/reimbursement scenario
      • 5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key country dynamic
      • 5.8.5.2. Regulatory framework/reimbursement scenario
      • 5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Medtronic
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Boston Scientific Corporation
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Cook Medical
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. CONMED Corporation
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Telemed Systems, Inc.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. HOBBS MEDICAL INC
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Becton, Dickinson and Company (BD)
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Olympus Corporation
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Horizons International Corp.
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Argon Medical Devices
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Erbe Elektromedizin GmbH
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives